Revance Therapeutics may soon run into an identity problem with a product that is so eagerly awaited that some people...
Read moreAfter unimpressive evidence on tumour progression, many Gilead Sciences investors have stopped believing in Trodelvy in HR-positive, HER2-negative breast cancer....
Read moreA group of type 1 antibodies recently made available by Bio-Rad Laboratories are intended to prevent the drug evolcumab from...
Read moreOn September 1, 2022, Novo Nordisk and Forma Therapeutics revealed that Novo Nordisk would buy Forma Therapeutics for for $1.1...
Read moreBy demonstrating a massive survival benefit, Keytruda's Keynote-189 study precipitated a turning point in the development of lung cancer medications....
Read moreThe treatment for paediatric patients with severe malaria is being evaluated through research. The first patient has been enrolled in...
Read moreFor intravenous infusion in paediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD), a rare genetic disorder that results in...
Read moreA new variation of the CRISPR-Cas9 gene editing system, according to researchers from the Gladstone Institutes and University of California...
Read moreAccording to complaints filed by Moderna, Pfizer and BioNTech's COVID-19 vaccine Comirnaty® violates patents the company filed between 2010 and...
Read moreA recent study predicts that the size of the global formulation development outsourcing market will increase from its value of...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.